The PennZone

CARTHAGE, Mo. - PennZone -- Stratum Nutrition^®, (a business of ESM Technologies), along with our Brazilian partner Ayalla, are pleased to announce that ANVISA, the National Health Surveillance Agency of the Brazilian Ministry of Health, has granted "safety and efficacy as a bioactive substance" pre-market approval of NEM® brand eggshell membrane on January 14, 2021. This approval was the culmination of a multi-year review by ANVISA of NEM's safety and efficacy substantiation, which is required for foods or bioactive substances claims in Brazil.

Sandra de Anselmo, President of Ayalla, said, "NEM is an innovative science-based ingredient approved for the first time by ANVISA in Brazil. We are very proud and excited to introduce such a robust ingredient to the Brazilian market and we are sure it will be a best-selling product in Brazil. We thank our partner, Stratum for the endless support they have given us through the approval process, and we hope to live up to their expectations just the same."

"Brazil marks the 3^rd rigorous regulatory agency review of NEM's safety and efficacy data, following Canadian and Australian approvals in recent years.  "We are extremely gratified to receive approval from ANVISA, as this again validates the substantial scientific portfolio that supports NEM and its health claims.  Brazil is a major market for joint health ingredients and we believe that an innovative, scientifically-backed ingredient like NEM will quickly establish itself as a category leader." said Kevin J. Ruff, Ph.D., MBA, Sr. Director of Scientific & Regulatory Affairs for Stratum Nutrition.

More on The PennZone

• Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
• Birkdale Investments LLC Acquires Assets of Mumbai Central Farmers Market, Unveils Expanded Vision
• RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
• UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
• International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea

NEM is one of the few joint health ingredients, and the only eggshell membrane ingredient that is supported by a full portfolio of 16 research studies, including: 4 randomized placebo-controlled trials (2 of which are healthy person trials); 4 open label clinical trials (3 of which were conducted independently); veterinary trials, including one canine RCT; and a wide range of supporting in vitro and in vivo mechanism of action studies.  In addition to subjective endpoints like joint pain and stiffness, recent clinical trials have included objective endpoints via the CTX-II cartilage degradation biomarker, giving the results additional credibility and substantiation.

Stratum is the global leader in eggshell membrane science and technology for joint health with products in over 20 countries. For more information about NEM® and other ingredients, please visit www.stratumnutrition.com.

###

About Stratum Nutrition

Stratum Nutrition^®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM^® brand eggshell membrane, ESC^® brand eggshell calcium, Ahiflower^® plant-based omegas-3,6,9, Curcumin 95, BioCurc^®, LBiome™ Lactobacillus LB postbiotic, Nataxtin^TM astaxanthin, as well as oral-cavity probiotics, BLIS K12™ and BLIS M18™. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

More on The PennZone

• The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
• LiteracyNation's 3rd Annual Indie Author Book Fair
• FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
• Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
• Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors